127 related articles for article (PubMed ID: 28224974)
1. Differences in outcomes in patients with stable coronary artery disease managed by cardiologists versus noncardiologists. Results from the international prospective CLARIFY registry.
Parma Z; Steg PG; Greenlaw N; Ferrari R; Ford I; Fox K; Tardif JC; Morais J; Gamba MA; Kääb S; Tendera For The Clarify Investigators M
Pol Arch Intern Med; 2017 Jan; 127(2):107-114. PubMed ID: 28224974
[TBL] [Abstract][Full Text] [Related]
2. β-Blocker use and clinical outcomes in stable outpatients with and without coronary artery disease.
Bangalore S; Steg G; Deedwania P; Crowley K; Eagle KA; Goto S; Ohman EM; Cannon CP; Smith SC; Zeymer U; Hoffman EB; Messerli FH; Bhatt DL;
JAMA; 2012 Oct; 308(13):1340-9. PubMed ID: 23032550
[TBL] [Abstract][Full Text] [Related]
3. Management and clinical outcome of stable coronary artery disease in Austria : Results from 5 years of the CLARIFY registry.
Lang IM; Badr-Eslam R; Greenlaw N; Young R; Steg PG
Wien Klin Wochenschr; 2017 Dec; 129(23-24):879-892. PubMed ID: 28913755
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of anginal symptoms and myocardial ischemia and their effect on clinical outcomes in outpatients with stable coronary artery disease: data from the International Observational CLARIFY Registry.
Steg PG; Greenlaw N; Tendera M; Tardif JC; Ferrari R; Al-Zaibag M; Dorian P; Hu D; Shalnova S; Sokn FJ; Ford I; Fox KM;
JAMA Intern Med; 2014 Oct; 174(10):1651-9. PubMed ID: 25110899
[TBL] [Abstract][Full Text] [Related]
5. β-blocker use in patients after percutaneous coronary interventions: one size fits all? Worse outcomes in patients without myocardial infarction or heart failure.
Ozasa N; Morimoto T; Bao B; Furukawa Y; Nakagawa Y; Kadota K; Iwabuchi M; Shizuta S; Shiomi H; Tazaki J; Natsuaki M; Kimura T;
Int J Cardiol; 2013 Sep; 168(2):774-9. PubMed ID: 23127614
[TBL] [Abstract][Full Text] [Related]
6. β-blockers, calcium antagonists, and mortality in stable coronary artery disease: an international cohort study.
Sorbets E; Steg PG; Young R; Danchin N; Greenlaw N; Ford I; Tendera M; Ferrari R; Merkely B; Parkhomenko A; Reid C; Tardif JC; Fox KM;
Eur Heart J; 2019 May; 40(18):1399-1407. PubMed ID: 30590529
[TBL] [Abstract][Full Text] [Related]
7. Rationale, design, and baseline characteristics of the CLARIFY registry of outpatients with stable coronary artery disease.
Sorbets E; Greenlaw N; Ferrari R; Ford I; Fox KM; Tardif JC; Tendera M; Steg PG;
Clin Cardiol; 2017 Oct; 40(10):797-806. PubMed ID: 28561986
[TBL] [Abstract][Full Text] [Related]
8. [Status of β-blocker use and heart rate control in Chinese patients with stable coronary artery disease].
Sun Y; Yu J; Hu D;
Zhonghua Xin Xue Guan Bing Za Zhi; 2016 Jan; 44(1):19-26. PubMed ID: 26813548
[TBL] [Abstract][Full Text] [Related]
9. Predictors, Trends, and Outcomes (Among Older Patients ≥65 Years of Age) Associated With Beta-Blocker Use in Patients With Stable Angina Undergoing Elective Percutaneous Coronary Intervention: Insights From the NCDR Registry.
Motivala AA; Parikh V; Roe M; Dai D; Abbott JD; Prasad A; Mukherjee D
JACC Cardiovasc Interv; 2016 Aug; 9(16):1639-48. PubMed ID: 27539683
[TBL] [Abstract][Full Text] [Related]
10. Management of outpatients in France with stable coronary artery disease. Findings from the prospeCtive observational LongitudinAl RegIstry oF patients with stable coronary arterY disease (CLARIFY) registry.
Danchin N; Ferrieres J; Guenoun M; Cattan S; Rushton-Smith SK; Greenlaw N; Ferrari R; Steg PG;
Arch Cardiovasc Dis; 2014; 107(8-9):452-61. PubMed ID: 25128934
[TBL] [Abstract][Full Text] [Related]
11. Current management and treatment of patients with stable coronary artery diseases presenting to cardiologists in different clinical contexts: A prospective, observational, nationwide study.
De Luca L; Temporelli PL; Lucci D; Gonzini L; Riccio C; Colivicchi F; Geraci G; Formigli D; Maras P; Falcone C; Di Lenarda A; Gulizia MM;
Eur J Prev Cardiol; 2018 Jan; 25(1):43-53. PubMed ID: 29124952
[TBL] [Abstract][Full Text] [Related]
12. Long-term clinical outcomes after percutaneous coronary intervention for ostial/mid-shaft lesions versus distal bifurcation lesions in unprotected left main coronary artery: the DELTA Registry (drug-eluting stent for left main coronary artery disease): a multicenter registry evaluating percutaneous coronary intervention versus coronary artery bypass grafting for left main treatment.
Naganuma T; Chieffo A; Meliga E; Capodanno D; Park SJ; Onuma Y; Valgimigli M; Jegere S; Makkar RR; Palacios IF; Costopoulos C; Kim YH; Buszman PP; Chakravarty T; Sheiban I; Mehran R; Naber C; Margey R; Agnihotri A; Marra S; Capranzano P; Leon MB; Moses JW; Fajadet J; Lefevre T; Morice MC; Erglis A; Tamburino C; Alfieri O; Serruys PW; Colombo A
JACC Cardiovasc Interv; 2013 Dec; 6(12):1242-9. PubMed ID: 24355114
[TBL] [Abstract][Full Text] [Related]
13. Heart rate and the use of beta-blockers in stable outpatients with coronary artery disease: Polish baseline results of the CLARIFY registry.
Stępińska J; Marona M; Greenlaw N; Steg G;
Kardiol Pol; 2014; 72(11):1156-64. PubMed ID: 25001472
[TBL] [Abstract][Full Text] [Related]
14. Comparison of clinical profile and management of outpatients with heart failure with reduced left ventricular ejection fraction treated by general practitioners and cardiologists in contemporary Poland: the results from the DATA-HELP registry.
Jankowska EA; Kalicinska E; Drozd M; Kurian B; Banasiak W; Ponikowski P
Int J Cardiol; 2014 Oct; 176(3):852-8. PubMed ID: 25156847
[TBL] [Abstract][Full Text] [Related]
15. Management strategies and 5-year outcomes in Polish patients with stable coronary artery disease versus other European countries: data from the CLARIFY registry.
Parma Z; Young R; Roleder T; Marona M; Ford I; Tendera M; Steg PG; Stępińska J
Pol Arch Intern Med; 2019 Apr; 129(5):327-334. PubMed ID: 30951032
[TBL] [Abstract][Full Text] [Related]
16. Demographic and clinical characteristics of patients with stable coronary artery disease: results from the CLARIFY registry in Spain.
Zamorano JL; García-Moll X; Ferrari R; Greenlaw N
Rev Esp Cardiol (Engl Ed); 2014 Jul; 67(7):538-44. PubMed ID: 24952393
[TBL] [Abstract][Full Text] [Related]
17. Mortality of Myocardial Infarction by Sex, Age, and Obstructive Coronary Artery Disease Status in the ACTION Registry-GWTG (Acute Coronary Treatment and Intervention Outcomes Network Registry-Get With the Guidelines).
Smilowitz NR; Mahajan AM; Roe MT; Hellkamp AS; Chiswell K; Gulati M; Reynolds HR
Circ Cardiovasc Qual Outcomes; 2017 Dec; 10(12):e003443. PubMed ID: 29246884
[TBL] [Abstract][Full Text] [Related]
18. Management of coronary artery disease patients in Latvia compared with practice in Central-Eastern Europe and globally: analysis of the CLARIFY registry.
Erglis A; Mintale I; Latkovskis G; Balode I; Jegere S; Bajare I; Rozenbergs A; Greenlaw N; Ferrari R; Steg PG;
Medicina (Kaunas); 2015; 51(4):240-6. PubMed ID: 26424189
[TBL] [Abstract][Full Text] [Related]
19. Comparison of a Simple Angiographic Approach With a Synergy Between Percutaneous Coronary Intervention With Taxus and Cardiac Surgery Score-Based Approach for Left Main Coronary Artery Stenting: A Pooled Analysis of Serial PRECOMBAT (Premier of Randomized Comparison of Bypass Surgery Versus Angioplasty Using Sirolimus-Eluting Stent in Patients With Left Main Coronary Artery Disease) Studies.
Lee PH; Lee JY; Lee CW; Kim SO; Ahn JM; Park DW; Kang SJ; Lee SW; Kim YH; Park SW; Park SJ
Circ Cardiovasc Interv; 2018 Jan; 11(1):e005374. PubMed ID: 29311287
[TBL] [Abstract][Full Text] [Related]
20. Beta-blocker therapy reduces mortality in patients with coronary artery disease treated with percutaneous revascularization: a meta-analysis of adjusted results.
Peyracchia M; Errigo D; Raposeiras Rubin S; Conrotto F; DiNicolantonio JJ; Omedè P; Rettegno S; Iannaccone M; Moretti C; D'Amico M; Gaita F; D'Ascenzo F
J Cardiovasc Med (Hagerstown); 2018 Jul; 19(7):337-343. PubMed ID: 29877974
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
